Category Archives: Pr Newswire

New MiniMed™ 780G system data demonstrates ability to address persistent blood sugar challenges for people with type 1 diabetes

With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn phenomenon, and improved overnight sleep DUBLIN and ORLANDO, Fla., June 21, 2024 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a comprehensive body of […]

FP Markets Adds Two More Industry Benchmark Awards to Its Collection

SYDNEY, June 21, 2024 /PRNewswire/ — Extending its winning streak, global multi-asset Forex and CFD broker, FP Markets, was crowned ‘Most Transparent Broker’ and also took home ‘Best Trading Conditions’ for the second year in a row at the highly anticipated Global Ultimate Fintech (UF) Awards 2024. Following last year’s ‘Most Trusted Broker’ acknowledgement and the […]

2024 World Intelligence Expo Begins with a Grand Opening in Tianjin

TIANJIN, China, June 22, 2024 /PRNewswire/ — On June 20th, Tianjin hosted the opening of the 2024 World Intelligence Expo (WIE). Under the theme “Intelligence: Expansive Development Space, Sustainable Growth Driver,” the event was co-organized by the people’s governments of the Tianjin and Chongqing municipalities. Wan Gang made a keynote speech. Chinese President Xi Jinping sent […]

Discover VIAIM’s Advanced Earbuds: Elevate Your Smart Office Experience with Real-time Conference Recording”

HEFEI, China, June 21, 2024 /PRNewswire/ — VIAIM, an AI technology hardware company deeply rooted in the smart office sector, has announced the upgrade of its brand-new official website, showcasing its innovative wireless earbuds. The upgraded website put spotlight on its flagship products, the AI Recoding True Wireless Earbuds VIAIM Nano+ and the Open-ear AI Recording True Wireless […]

Lexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 Diabetes

Lexicon Seeks Approval for Sotagliflozin as an Adjunct to Insulin Therapy for Glycemic Control in People with Type 1 Diabetes and Chronic Kidney Disease Company Anticipates Six Month Review and Potential Launch in Early 2025 THE WOODLANDS, Texas, June 21, 2024 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that, following multiple interactions […]

Aprea Therapeutics to Host Virtual KOL Event on APR-1051, a Highly Selective and Potentially Best-in-Class Oral WEE1 Inhibitor, on Monday, June 24, 2024

Webinar will include discussion of APR-1051 in context of emerging WEE1 inhibitor landscape DOYLESTOWN, Pa., June 21, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced that it will host a virtual KOL event to discuss APR-1051, a […]

Acasti Announces Year-End 2024 Financial Results, Provides Business Update

Patient Enrollment in Pivotal STRIVE-ON Phase 3 Safety Trial for GTX-104 On-Track for Potential NDA Submission in 1H Calendar 2025 Projected Cash Runway into Second Calendar Quarter 2026 PRINCETON, N.J., June 21, 2024 (GLOBE NEWSWIRE) —  Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation […]

Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27

CHARLOTTE, N.C. and MELBOURNE, Australia, June 21, 2024 (GLOBE NEWSWIRE) — Genetic Technologies Limited (NASDAQ:GENE, ASX:GTG, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on June 27, 2024, at 4:15 p.m. ET. The exclusive event, hosted by […]

Clene Presents Preliminary Data for CNM-Au8® as a Potential Treatment for Rett Syndrome

CNM-Au8 demonstrated neuroprotective effects in an in vitro model of Rett Syndrome, a rare pediatric neurodevelopmental disease CNM-Au8 also demonstrated rescue of mitochondrial deficits in induced astrocytes derived from Rett patients Invited oral presentation and poster presented on June 19, 2024, at the International Rett Syndrome Foundation 2024 Annual Meeting in Westminster, Colorado SALT LAKE […]

Tianjin Advances with AI

BEIJING, June 21, 2024 /PRNewswire/ —  A report from China Daily: China’s status as a leading industrial powerhouse in the world will become even more pronounced in the era of AI, as artificial intelligence technology continues to advance in China and the digitalization of the manufacturing industry progresses further, said business leaders and experts on […]